{"entity":{"entity_id":"48be8d02-aec8-4ef2-91ba-7b2968226e02","entity_url":"https://factanker.com/entity/48be8d02-aec8-4ef2-91ba-7b2968226e02","label":"MARKER THERAPEUTICS, INC.","type":"org","anchors":{"cik":"0001094038"}},"answer":"In fiscal year 2025, US federal contract obligations equal at least 99.9% of MARKER THERAPEUTICS, INC.'s reported revenue - $3.5M in federal awards against $3.5M in revenue as filed with the SEC.","cite_as":"FACTANKER, https://factanker.com/entity/48be8d02-aec8-4ef2-91ba-7b2968226e02/government-dependency","method":"EDGAR revenue (company fiscal year) against USAspending obligations (federal fiscal year of the award date); identity via evidence-backed same_as facts.","series":[{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2025,"revenue_usd":3546669.0,"obligations_usd":3541289.0,"awards":5,"gov_share":0.9985,"data_completeness":"contracts_only"},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2024,"revenue_usd":6591080.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2023,"revenue_usd":3311133.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2022,"revenue_usd":3513544.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2021,"revenue_usd":1241710.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2020,"revenue_usd":466785.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2019,"revenue_usd":213194.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2018,"revenue_usd":205994.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"MARKER THERAPEUTICS, INC.","cik":"0001094038","lei":null,"qid":null,"uei":"CK3KR85CSP23","ein":null,"fiscal_year":2017,"revenue_usd":183064.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null}],"not_claimed":["Obligations are federal fiscal years (Oct–Sep), revenue is the company's fiscal year — the periods do not align exactly.","For years with data_completeness='contracts_only' only contracts are loaded, assistance is still missing — for grant recipients the total is therefore too low."],"retrieved_at":"2026-09-06T12:16:01"}